Galectin Therapeutics shares owned by Buckingham Asset Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Buckingham Asset Management
from 13F filings
Historical chart of Buckingham Asset Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Buckingham Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Buckingham Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $22k | 13k | 1.66 |
| 2023-09-30 | $25k | 13k | 1.92 |
| 2023-06-30 | $19k | 13k | 1.44 |
| 2023-03-31 | $15k | 13k | 1.13 |
| 2022-12-31 | $15k | 13k | 1.13 |
| 2022-09-30 | $22k | 13k | 1.66 |
| 2022-06-30 | $17k | 13k | 1.28 |
| 2022-03-31 | $21k | 13k | 1.59 |
| 2021-12-31 | $27k | 13k | 2.04 |
| 2021-09-30 | $42k | 11k | 3.91 |
| 2019-03-31 | $51k | 10k | 5.10 |
| 2018-12-31 | $34k | 10k | 3.40 |
| 2018-09-30 | $60k | 10k | 6.00 |
| 2018-06-30 | $64k | 10k | 6.40 |
| 2018-03-31 | $47k | 10k | 4.70 |
| 2017-12-31 | $33k | 10k | 3.30 |
| 2017-09-30 | $107k | 50k | 2.14 |
| 2017-06-30 | $123k | 50k | 2.46 |
| 2017-03-31 | $115k | 50k | 2.30 |
More positions owned by Buckingham Asset Management
View all positions for Buckingham Asset Management